These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 20419598

  • 1. IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease.
    Mitchell J, Dimov V, Townley RG.
    Curr Opin Investig Drugs; 2010 May; 11(5):527-34. PubMed ID: 20419598
    [Abstract] [Full Text] [Related]

  • 2. Immune modulation for treatment of allergic disease.
    Nguyen TH, Casale TB.
    Immunol Rev; 2011 Jul; 242(1):258-71. PubMed ID: 21682751
    [Abstract] [Full Text] [Related]

  • 3. [Inflammatory cytokines (IL-4, IL-5 and IL-13)].
    Maeda S, Yanagihara Y.
    Nihon Rinsho; 2001 Oct; 59(10):1894-9. PubMed ID: 11676128
    [Abstract] [Full Text] [Related]

  • 4. Targeting memory Th2 cells for the treatment of allergic asthma.
    Epstein MM.
    Pharmacol Ther; 2006 Jan; 109(1-2):107-36. PubMed ID: 16081161
    [Abstract] [Full Text] [Related]

  • 5. Targeting T cells for asthma.
    Heijink IH, Van Oosterhout AJ.
    Curr Opin Pharmacol; 2005 Jun; 5(3):227-31. PubMed ID: 15907907
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Agents against cytokine synthesis or receptors.
    Yamagata T, Ichinose M.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):289-301. PubMed ID: 16457805
    [Abstract] [Full Text] [Related]

  • 8. Pitrakinra for asthma.
    Antoniu SA, Cojocaru I.
    Expert Opin Biol Ther; 2010 Nov 08; 10(11):1609-15. PubMed ID: 20923253
    [Abstract] [Full Text] [Related]

  • 9. IL-13 as a therapeutic target for respiratory disease.
    Kasaian MT, Miller DK.
    Biochem Pharmacol; 2008 Jul 15; 76(2):147-55. PubMed ID: 18502398
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-13 in asthma pathogenesis.
    Wills-Karp M.
    Immunol Rev; 2004 Dec 15; 202():175-90. PubMed ID: 15546393
    [Abstract] [Full Text] [Related]

  • 11. Th2 cells as targets for therapeutic intervention in allergic bronchial asthma.
    Wegmann M.
    Expert Rev Mol Diagn; 2009 Jan 15; 9(1):85-100. PubMed ID: 19099351
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of interleukin-13 in infectious diseases and allergy.
    Brombacher F.
    Bioessays; 2000 Jul 15; 22(7):646-56. PubMed ID: 10878577
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Allergy, Allergic Inflammation and Asthma--Keystone Symposium. Pharmacological targets in allergic inflammation and asthma.
    Kierstein S.
    IDrugs; 2006 Jun 15; 9(6):405-8. PubMed ID: 16752308
    [No Abstract] [Full Text] [Related]

  • 17. IL-13 from Th2-type cells suppresses induction of antigen-specific Th1 immunity in a T-cell lymphoma.
    Deepak P, Kumar S, Kishore D, Acharya A.
    Int Immunol; 2010 Jan 15; 22(1):53-63. PubMed ID: 19951958
    [Abstract] [Full Text] [Related]

  • 18. A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma.
    Bagnasco D, Ferrando M, Varricchi G, Passalacqua G, Canonica GW.
    Int Arch Allergy Immunol; 2016 Jan 15; 170(2):122-31. PubMed ID: 27637004
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modulation of the human IgE response.
    de Vries JE, Yssel H.
    Eur Respir J Suppl; 1996 Aug 15; 22():58s-62s. PubMed ID: 8871045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.